156 related articles for article (PubMed ID: 8098269)
1. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas.
Nishiyama K; Shirahama T; Yoshimura A; Sumizawa T; Furukawa T; Ichikawa-Haraguchi M; Akiyama S; Ohi Y
Cancer; 1993 Jun; 71(11):3611-9. PubMed ID: 8098269
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Nakazima Y; Akiyama S
Biochim Biophys Acta; 1991 Mar; 1073(2):309-15. PubMed ID: 1672608
[TBL] [Abstract][Full Text] [Related]
3. Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype.
Rochlitz CF; Lobeck H; Peter S; Reuter J; Mohr B; de Kant E; Huhn D; Herrmann R
Cancer; 1992 Jun; 69(12):2993-8. PubMed ID: 1350506
[TBL] [Abstract][Full Text] [Related]
4. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
[TBL] [Abstract][Full Text] [Related]
5. Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.
Yang CP; Mellado W; Horwitz SB
Biochem Pharmacol; 1988 Apr; 37(7):1417-21. PubMed ID: 2895656
[No Abstract] [Full Text] [Related]
6. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
7. Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.
Bak M; Efferth T; Mickisch G; Mattern J; Volm M
Eur Urol; 1990; 17(1):72-5. PubMed ID: 1969346
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
[TBL] [Abstract][Full Text] [Related]
9. Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell.
Ichikawa M; Yoshimura A; Sumizawa T; Shudo N; Kuwazuru Y; Furukawa T; Akiyama S
J Biol Chem; 1991 Jan; 266(2):903-8. PubMed ID: 1670776
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of P-glycoprotein in kidney and urinary bladder cancers.
Moriyama M; Sugawara I; Hamada H; Tsuruo T; Kato T; Sato K; Hikage T; Watanuki T; Mori S
Tohoku J Exp Med; 1991 Jul; 164(3):191-201. PubMed ID: 1684451
[TBL] [Abstract][Full Text] [Related]
11. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
12. Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells.
Poruchynsky MS; Ling V
Biochemistry; 1994 Apr; 33(14):4163-74. PubMed ID: 7908829
[TBL] [Abstract][Full Text] [Related]
13. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
Bruggemann EP; Germann UA; Gottesman MM; Pastan I
J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter.
Tanaka S; Currier SJ; Bruggemann EP; Ueda K; Germann UA; Pastan I; Gottesman MM
Biochem Biophys Res Commun; 1990 Jan; 166(1):180-6. PubMed ID: 1967936
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein.
Georges E; Zhang JT; Ling V
J Cell Physiol; 1991 Sep; 148(3):479-84. PubMed ID: 1680871
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1992; 22(2):158-62. PubMed ID: 1362155
[TBL] [Abstract][Full Text] [Related]
17. Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.
Kawamoto S; Deguchi T; Nezasa S; Yamada S; Okano M; Kawada Y
Jpn J Cancer Res; 1996 May; 87(5):475-9. PubMed ID: 8641984
[TBL] [Abstract][Full Text] [Related]
18. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
Volm M; Mattern J; Efferth T; Pommerenke EW
Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
[TBL] [Abstract][Full Text] [Related]
19. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
Greenberger LM
J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
[TBL] [Abstract][Full Text] [Related]
20. Expression of MDR1/P glycoprotein in human sarcomas.
Vergier B; Cany L; Bonnet F; Robert J; de Mascarel A; Coindre JM
Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
